scispace - formally typeset
S

Stephen Brimijoin

Researcher at Mayo Clinic

Publications -  202
Citations -  7707

Stephen Brimijoin is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Acetylcholinesterase & Butyrylcholinesterase. The author has an hindex of 47, co-authored 202 publications receiving 7402 citations. Previous affiliations of Stephen Brimijoin include University of Minnesota & University of Nebraska Medical Center.

Papers
More filters
Journal ArticleDOI

Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.

TL;DR: The generally high levels of BChE activity in tissues, including the motor endplate, and the observation that mice live without AChE, suggest that B ChE has an essential function in nullizygous mice and probably in wild‐type mice as well.
Journal ArticleDOI

Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase STEPS TOWARD NOVEL DRUGS FOR TREATING ALZHEIMER'S DISEASE

TL;DR: The present work and previous computational studies strongly suggest that a low affinity THA peripheral site exists in AChE, and this peripheral site provides a structural basis for design of improved cholinesterase ligands for treating Alzheimer's disease and for other health-related purposes.
Journal ArticleDOI

Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig

TL;DR: The behavior of SPLI during ultracentrifugation of nerve and ganglion extracts indicated that this peptide was normally present both in a soluble form and in association with particles but was transported primarily in the latter form.
Journal ArticleDOI

Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex.

TL;DR: The authors showed that AChE may play a role in pathogenesis of Alzheimer's disease at 9-12 months of the mouse's life, and that plaque onset in the hybrids occurred 30-50% sooner than in the parental lines.